Clinical Trial Update: Hu8F4 in Treating Patients With Advanced Hematologic Malignancies [Phase 1]

View source ↗

Summary

Hu8F4 is being studied in a Phase 1 trial for multiple advanced hematologic malignancies; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
• Blast Phase Chronic Myeloid Leukemia Bcr-abl1-positive
• High-risk Myelodysplastic Syndrome
• Myelodysplastic Syndrome with Excess Blasts-1
• Myelodysplastic Syndrome with Excess Blasts-2
• Myelomonocytic Leukemia

Drugs mentioned

• Hu8F4

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 1 | Status: ACTIVE_NOT_RECRUITING